Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
Y Qin, X Zheng, W Gao, B Wang, Y Wu - Molecular Therapy-Oncolytics, 2021 - cell.com
Head and neck squamous cell carcinomas (HNSCCs) are a type of common malignant
tumor, mainly manifesting as oropharyngeal, oral cavity, laryngopharyngeal …
tumor, mainly manifesting as oropharyngeal, oral cavity, laryngopharyngeal …
The head and neck squamous cell carcinoma microenvironment as a potential target for cancer therapy
J Plzák, J Bouček, V Bandúrová, M Kolář, M Hradilová… - Cancers, 2019 - mdpi.com
Similarly to other types of malignant tumours, the incidence of head and neck cancer is
increasing globally. It is frequently associated with smoking and alcohol abuse, and in a …
increasing globally. It is frequently associated with smoking and alcohol abuse, and in a …
Salivary exosomal MicroRNA-486-5p and MicroRNA-10b-5p in oral and oropharyngeal squamous cell carcinoma
Background and Objectives: The research aimed at evaluating the capacity of salivary
exosomal miR-10b-5p and miR-486-5p for oral and oropharyngeal cancer detection …
exosomal miR-10b-5p and miR-486-5p for oral and oropharyngeal cancer detection …
Boron neutron capture therapy at the crossroads-Where do we go from here?
RF Barth, JC Grecula - Applied Radiation and Isotopes, 2020 - Elsevier
As elegant as is the concept upon which Boron Neutron Capture Therapy (BNCT) is based,
unfortunately it has not gained widespread acceptance by the physicians who are treating …
unfortunately it has not gained widespread acceptance by the physicians who are treating …
Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors
H Sun, L Chen, R Huang, H Pan, Y Zuo, R Zhao… - Frontiers in …, 2022 - frontiersin.org
Objective Although the application of immunotherapy in gastric cancer has achieved
satisfactory clinical effects, many patients have no response. The aim of this retrospective …
satisfactory clinical effects, many patients have no response. The aim of this retrospective …
Prognostic value of 18F-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer
Objectives By comparing the prognostic performance of 18F-FDG PET/CT-based radiomics
combining dose features [Includes Dosiomics feature and the dose volume histogram (DVH) …
combining dose features [Includes Dosiomics feature and the dose volume histogram (DVH) …
A new detection method of oral and oropharyngeal squamous cell carcinoma based on multivariate analysis of surface enhanced raman spectra of salivary exosomes
Raman spectroscopy recently proved a tremendous capacity to identify disease-specific
markers in various (bio) samples being a non-invasive, rapid, and reliable method for cancer …
markers in various (bio) samples being a non-invasive, rapid, and reliable method for cancer …
The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas
L de Vos, I Grünwald, EG Bawden, J Dietrich… - Epigenetics, 2020 - Taylor & Francis
ABSTRACT CTLA-4 blocking therapeutic antibodies are currently under investigation in
head and neck squamous cell carcinoma (HNSCC). A better understanding of the …
head and neck squamous cell carcinoma (HNSCC). A better understanding of the …
Salivary exosomal microRNAs as biomarkers for head and neck cancer detection—a literature review
Background MicroRNAs (miRs) are small, non-coding mRNA molecules which regulate
cellular processes in tumorigenesis. miRs were discovered in extracellular environment and …
cellular processes in tumorigenesis. miRs were discovered in extracellular environment and …
Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy
Objectives The aim of this pilot study is to identify the genetic factors that contribute to the
response of metronomic chemotherapy in head and neck squamous cell carcinoma …
response of metronomic chemotherapy in head and neck squamous cell carcinoma …